Related Experiment Video
Updated: Mar 31, 2026
08:46
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
Published on: August 12, 2020
7.1K
Neonatal Sepsis: Pathogens, Clinical Challenges, and Emerging Solutions
Matthew Green1, Jyotsna Chawla1, Cyril Blavo1
1Foundational Sciences, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Clearwater, USA.
Cureus
|March 30, 2026
Summary
Neonatal sepsis is a leading cause of newborn deaths. Innovations in diagnostics, vaccines, and therapies offer new hope for prevention and treatment, but equitable access is crucial.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Public Health
Background:
- Neonatal sepsis causes significant preventable newborn mortality globally.
- Challenges include diagnostic delays, antimicrobial resistance (AMR), and resource inequality.
- Urgent need for novel strategies to combat neonatal infections.
Purpose of the Study:
- To review pathogens, transmission, and clinical aspects of neonatal sepsis.
- To examine emerging innovations for sepsis prevention and treatment.
- To advocate for standardized protocols and equitable global implementation.
Main Methods:
- Literature review of neonatal sepsis pathogens and clinical presentations.
- Analysis of advancements in diagnostics (molecular, NGS), AI, maternal vaccination, and immunotherapies.
- Synthesis of current evidence to identify global care gaps.
Main Results:
- Identified primary pathogens and their characteristics in early- and late-onset sepsis.
- Highlighted potential of new technologies like rapid diagnostics and AI.
- Emphasized the role of maternal vaccination and immunotherapies.
Conclusions:
- Innovations offer transformative potential for neonatal sepsis management.
- Standardized protocols and equitable access are essential for global impact.
- Reducing the global burden of neonatal sepsis requires integrated advancements.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
33
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
33
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
6.6K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.6K
01:22Healthcare Associated Infections II: Preventive Measures
4.9K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.9K
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
649
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
649
01:28Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
01:29Staphylococcal Skin Infections
62
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
62